Sprout Health Review 2026: GLP-1 Pricing, Program Details & Trimi Comparison
An honest, thorough review of Sprout Health's GLP-1 weight loss program in 2026. We evaluate their compounded semaglutide and tirzepatide offerings, pricing structure, clinical quality, patient experience, and how they compare to Trimi's $99/month semaglutide program.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. This review was last updated 2026-04-09. We review GLP-1 providers to help patients find the best combination of price, clinical quality, and long-term support.
Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.
More on GLP-1 Provider Comparisons
What Is Sprout Health and How Does It Work?
Sprout Health is a telehealth weight loss provider operating at sprouthealth.com. The platform follows the standard GLP-1 telehealth model: patients complete an online health intake, a licensed provider reviews their information and determines eligibility, a prescription is issued for compounded medication, and the medication ships directly from a pharmacy partner to the patient's door. Sprout Health prescribes both compounded semaglutide and compounded tirzepatide — the same active pharmaceutical ingredients found in brand-name Ozempic, Wegovy, Mounjaro, and Zepbound.
As a newer entrant in the GLP-1 telehealth market, Sprout Health is still building its clinical track record and patient review base. Coverage from outlets like US News suggests they meet minimum standards of legitimacy and are gaining broader visibility. However, newer providers inherently carry more uncertainty than established platforms with years of operational data. Patients considering Sprout Health should weigh the emerging nature of the provider against its pricing and services relative to alternatives.
The GLP-1 telehealth market has expanded significantly since 2022, with dozens of providers now offering compounded semaglutide and tirzepatide. Competition on price is fierce, and the range of quality varies considerably. Understanding exactly what any provider is offering — and at what cost — is the most important first step for any prospective patient.
For a broader overview of how these medications work and which conditions qualify for treatment, see our complete guide to GLP-1 medications and our GLP-1 candidacy guide.
Sprout Health Pricing in 2026
Sprout Health's pricing for 2026 falls in the approximate range of $150 to $300 per month, varying by medication type and dosage. This pricing is within the competitive mid-range for GLP-1 telehealth providers, though it is meaningfully higher than the lowest-cost options on the market. Sprout Health does not always publish full pricing upfront, which can create friction for patients trying to compare total costs before committing to a consultation.
| Cost Element | Sprout Health | Trimi |
|---|---|---|
| Semaglutide (monthly) | ~$150–$250/mo (varies by dose) | $99/mo flat — all-inclusive |
| Tirzepatide (monthly) | ~$200–$300/mo (varies by dose) | $125/mo flat — all-inclusive |
| Consultation fees | Varies; may be included | Always included |
| Shipping | Varies by plan | Free — included |
| Contract / commitment | Varies; verify before enrolling | Month-to-month — no contract |
| Pricing transparency | Partial — not always upfront | Full — published on website |
| Estimated 12-month total (semaglutide) | ~$1,800–$3,000 | $1,188 |
Pricing Verification Note
Prices for Sprout Health and all GLP-1 telehealth providers are subject to change. Always verify current pricing directly with Sprout Health at sprouthealth.com and with Trimi at trytrimi.com/pricing before making a decision.
The price gap between Sprout Health and Trimi — approximately $600 to $1,800 per year on semaglutide — is material. For many patients, this represents the single largest factor in provider selection. Because the compounded medication is pharmacologically identical across providers when sourced from accredited pharmacies, price differences primarily reflect operational structure, overhead, and business model rather than differences in the drug itself.
Sprout Health Program Details
Sprout Health's GLP-1 program follows the standard telehealth workflow. New patients complete an online intake questionnaire covering health history, current medications, BMI, and weight loss goals. A licensed provider reviews this information asynchronously and, if the patient qualifies, issues a prescription for compounded semaglutide or tirzepatide. The prescription is sent to a pharmacy partner for preparation and shipped to the patient's address.
As an emerging provider, Sprout Health is building out its clinical support infrastructure. Ongoing clinical touchpoints — including dose titration, side effect management, and check-ins — are part of the GLP-1 treatment experience and should be a key factor in your provider evaluation. Patients should ask specifically how Sprout Health handles dose adjustment requests and what response time to expect when contacting their provider team.
For patients who want detailed clinical guidance on dosing, side effects, and what to expect during GLP-1 treatment, our GLP-1 side effects guide and semaglutide dosing schedule guide provide thorough, clinically reviewed information regardless of which provider you choose.
What Sprout Health Does Well
A fair review requires recognizing what Sprout Health does well. As a newer provider, they have entered a competitive market and are building a track record that, based on early reviews and media coverage, is trending positively.
Offers both compounded semaglutide and tirzepatide — two of the most effective GLP-1 medications available
Emerging positive review base with coverage from credible outlets including US News
Telehealth-first model provides convenient access without in-person visits
Growing provider network expanding patient access across U.S. states
Standard asynchronous consultation model is quick and easy for eligible patients
Focused on weight loss as a core service, not a secondary product category
Where Sprout Health Falls Short
Despite its promising early trajectory, Sprout Health has notable areas of concern for patients conducting a thorough comparison.
Pricing ($150–$300/mo) is significantly higher than the lowest-cost comparable providers
Pricing transparency is partial — full costs are not always disclosed before beginning the intake process
As a newer provider, their clinical track record and long-term outcome data are limited
Review volume remains smaller than established competitors, making peer experience harder to evaluate
Plan terms and commitment structures should be carefully verified — variable across the market
Less specialized clinical infrastructure than dedicated metabolic health platforms with more tenure
Pharmacy sourcing details may be less thoroughly documented than with established providers
Sprout Health vs Trimi: Which Is the Better Value?
Both Sprout Health and Trimi offer compounded GLP-1 medications through a telehealth model. The medications are pharmacologically equivalent when sourced from accredited pharmacies. The differences come down to price, specialization, transparency, and track record.
On price, Trimi charges $99 per month for compounded semaglutide and $125 per month for compounded tirzepatide — both all-inclusive. This represents the most affordable pricing tier in the GLP-1 telehealth market. Sprout Health's pricing in the $150 to $300 range means patients pay roughly 1.5 to 3 times more for a medication that carries the same active ingredient. Over a twelve-month treatment course, this difference ranges from approximately $600 to $1,800.
On specialization, Trimi focuses exclusively on metabolic health and GLP-1 weight management. Every provider on the platform works in this specific clinical area daily. This specialization translates into nuanced knowledge of GLP-1 dosing protocols, side effect management, and titration timelines that general telehealth providers may not match. For patients who want expert clinical oversight of their GLP-1 treatment, specialization matters beyond just medication access.
On transparency, Trimi publishes its pricing openly on the website — $99 and $125 per month — with no hidden fees, no mandatory upsells, and no ambiguous plan structures. Sprout Health's pricing requires more investigation before a patient can calculate their true monthly cost.
On track record, Trimi has a longer operational history and a larger verified patient review base. For an emerging provider like Sprout Health, the smaller review set makes it harder to evaluate the consistency of their clinical experience and support quality. This does not mean Sprout Health is a poor choice — only that the evidence base is thinner.
For a broader comparison across multiple providers, see our best GLP-1 provider guide and our guide to finding the cheapest GLP-1 injections in 2026.
Who Should Consider Sprout Health?
Sprout Health may be a reasonable consideration for patients who:
- Have done thorough due diligence on the provider, confirmed pharmacy accreditation, and are comfortable with a newer platform
- Are located in a state where Trimi or other established lower-cost providers are currently not available
- Have been referred specifically by a healthcare provider familiar with Sprout Health's clinical team
- Have independently verified current pricing and plan terms and find the total cost acceptable
For most patients, however, the combination of higher pricing, limited pricing transparency, and smaller clinical track record makes Sprout Health a harder value proposition to justify compared to established providers with lower costs and longer operational histories. Patients for whom cost is a meaningful factor should carefully calculate total annual expenses before committing. Our guide to buying semaglutide online safely provides a framework for evaluating any GLP-1 telehealth provider.
Questions to Ask Any GLP-1 Provider Before Starting
Whether you are evaluating Sprout Health or any other GLP-1 telehealth provider, these questions help you make an informed decision:
What is the complete monthly cost, including medication, consultation, shipping, and any platform fees?
Which pharmacy prepares my medication, and is that pharmacy licensed as a 503B or PCAB/NABP accredited facility?
Is there a minimum commitment period, and what happens if I need to cancel before that period ends?
How are dose adjustments handled, and what is the typical turnaround time?
What is the process if I experience side effects and need clinical guidance quickly?
Are providers specialized in GLP-1 weight management, or do they cover multiple clinical areas?
How is my medication stored and shipped to ensure stability?
These questions apply equally to Sprout Health, Trimi, and any other provider. A platform that cannot answer them clearly and directly is a provider worth reconsidering.
The Verdict: Promising Entrant, but Price Premium Is Hard to Justify
Sprout Health is a legitimate, emerging GLP-1 telehealth provider that has received credible coverage and is building a positive early reputation. Their willingness to offer both compounded semaglutide and tirzepatide through a telehealth model is appropriate, and their early patient feedback suggests a functional and competent service.
However, the value proposition weakens significantly on price. At $150 to $300 per month, Sprout Health costs substantially more than providers like Trimi, which offers compounded semaglutide at $99 per month and compounded tirzepatide at $125 per month — with full pricing transparency and a month-to-month structure. The compounded medication is pharmacologically equivalent. The price difference is not.
For patients who have independently evaluated Sprout Health, are comfortable with a newer provider, and find their pricing acceptable, they may have a positive experience. For patients whose primary goals are clinical quality, pricing transparency, and maximum affordability, the evidence currently favors established, specialized providers. As Sprout Health matures and builds a longer track record, this assessment may change — but in 2026, the value case is not compelling relative to lower-cost alternatives.
For additional context, see our Calibrate review and our Henry Meds review for comparisons across the broader competitive landscape.
Frequently Asked Questions
What is Sprout Health?
Sprout Health (sprouthealth.com) is an emerging telehealth provider specializing in GLP-1 weight loss treatment. The platform connects patients with licensed healthcare providers who can prescribe compounded semaglutide and tirzepatide, the same active ingredients found in brand-name Ozempic, Wegovy, Mounjaro, and Zepbound. Sprout Health has grown its patient base steadily since entering the market and has received coverage from outlets including US News. As a newer entrant, their review volume is still growing but trends positively.
How much does Sprout Health cost in 2026?
Sprout Health pricing in 2026 typically falls in the $150 to $300 per month range depending on medication type, dosage level, and plan selected. Exact pricing can vary and is not always disclosed upfront, which can make side-by-side comparison difficult. Trimi offers compounded semaglutide at a flat $99 per month and compounded tirzepatide at $125 per month — both all-inclusive with no hidden fees. Over twelve months, Trimi's semaglutide program costs $1,188 compared to a potential $1,800 to $3,600 with Sprout Health.
Is Sprout Health legitimate?
Yes, Sprout Health appears to operate as a legitimate telehealth platform with licensed providers and pharmacy partnerships. They have received coverage from credible outlets and are building a verified patient review base. As with any emerging provider, patients should verify current licensing, confirm pharmacy accreditation, and review their cancellation and refund policies before enrolling. Legitimacy and best value are separate considerations — always compare multiple providers.
Does Sprout Health prescribe compounded GLP-1 medications?
Yes, Sprout Health offers compounded semaglutide and tirzepatide. Compounded versions contain the same active pharmaceutical ingredients as brand-name GLP-1 medications but are produced by licensed compounding pharmacies rather than the original manufacturer. When sourced from properly licensed and accredited pharmacies, compounded GLP-1 medications are a safe and legal alternative to brand-name drugs at substantially lower cost. Both Sprout Health and Trimi use compounded formulations.
How does Sprout Health compare to Trimi?
Both Sprout Health and Trimi are telehealth providers offering compounded GLP-1 medications. The clearest difference is pricing: Trimi charges a flat $99 per month for semaglutide and $125 per month for tirzepatide, while Sprout Health's pricing is typically in the $150 to $300 range. Both platforms include provider consultations and medication delivery. Trimi focuses exclusively on metabolic health and weight management, with dedicated specialists who work in this area daily. Sprout Health is a newer entrant with a growing — though smaller — clinical track record.
Does Sprout Health require long-term contracts?
Sprout Health plan terms should be verified directly with the provider, as commitment structures vary across telehealth GLP-1 platforms. Some emerging providers structure plans on a quarterly or annual basis to offer lower per-month rates. Trimi operates strictly on a month-to-month basis with no long-term contracts — patients can pause or cancel at any time without penalty.
What should I look for when choosing between Sprout Health and other GLP-1 providers?
Key factors to evaluate include: total monthly cost inclusive of all fees, pharmacy accreditation status (ideally 503B or PCAB/NABP accredited), provider qualifications and specialization in weight management, delivery speed and reliability, quality of ongoing clinical support including dose titration guidance, and the transparency of the cancellation policy. On pricing, Trimi's $99/month for semaglutide and $125/month for tirzepatide represents among the most competitive rates in the market. On specialization, Trimi's exclusive focus on metabolic health means providers are expert in GLP-1 clinical management.
Sources & References
- Sprout Health. Official program and pricing information. sprouthealth.com. 2026.
- STEP 1 trial: semaglutide in adults with overweight or obesity (PubMed).
- SURMOUNT-1 trial: tirzepatide once weekly for the treatment of obesity (PubMed).
- FDA guidance on compounding and the FDA.
- NABP compounding pharmacy accreditation standards.
- NIDDK: Prescription medications to treat overweight and obesity.
- American Board of Obesity Medicine. Standards of Practice in Obesity Medicine. 2025.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any weight loss medication or program. Trimi is a competing provider to Sprout Health — this review aims to be fair and factual, but readers should verify current pricing, program details, and clinical information directly with Sprout Health at sprouthealth.com.